astatine-211 CLR 12120

N/A

Report date: 2025/09/10 10:58:21

NME

Base Information

Drug Nameastatine-211 CLR 12120

Drug Alias Nameastatine-211 CLR-12120211At-CLR-12120

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Astatine > 211At

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsPancreatic NeoplasmsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCellectar Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesCellectar Biosciences Inc

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A